Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.

Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.

In the evolving landscape of pharmaceutical production, fill-finish contract manufacturing has become a crucial area of focus ...

The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...

Pharma Lessons has added two new bonus modules to the popular Good Manufacturing Practice Training. The new modules are already available to all currently enrolled users.The first module covers the ...

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action ...

India now has a network of 752 FDA-approved, 2,050 WHO GMP-certified, 286 EDQM-approved ... There has been a 27% decline in European Medicines Agency (EMA) noncompliance, in the same period.

India’s pharmaceutical sector, the world’s largest supplier of generic medicines, is poised for a new era of growth with ...

TCS is currently testing the lower boundary of a falling channel while holding above the 100-week EMA and the long-term ascending trendline support. This confluence suggests a potential rebound ...

announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the European market. C3i, therefore, obtains a certificate of GMP ...